Aripiprazole-induced transient myopia

dc.authoridYeşil Örnek, Bahar/0000-0003-0873-4589
dc.authoridGündüz, Abuzer/0000-0003-1752-6810
dc.authorwosidYeşil Örnek, Bahar/AAB-4751-2022
dc.authorwosidGündüz, Abuzer/HLH-2417-2023
dc.contributor.authorCumurcu, Tongabay
dc.contributor.authorCumurcu, Birgul Elbozan
dc.contributor.authorYesil, Bahar
dc.contributor.authorGunduz, Abuzer
dc.date.accessioned2024-08-04T20:10:32Z
dc.date.available2024-08-04T20:10:32Z
dc.date.issued2020
dc.departmentİnönü Üniversitesien_US
dc.description.abstractThis study aims to present a case of transient myopia due to aripiprazole used in the treatment of depression. A 21-year-old female who was being treated for depression with 15 mg/day Aripiprazole during two months. She normally used -3.75 D glasses. She was admitted to our outpatient clinic with sudden onset blurring of vision in both eyes despite using glasses for about three days. Using of aripiprazole was observed in the patient's history. She was found to have myopia of -6.0 diopters in both eyes with measurement of otorefractometer; her visual acuity was 6/10 in both eyes with her glasses. The other eye examination findings of the patient were normal. The drug was discontinued, and the patient was followed. One mount later on examination, the patient's visual acuity increased to 10/10 in both eyes. Following the first day of the Alx values measured were 0.3 mm longer than one month after the measurement; the minimal difference between the other anterior segment findings were recorded. Although the specific mechanisms that cause acute myopia has not been fully revealed, it can be ciliary spasm, ciliary bodies effusion, peripheral uveal effusion and effects of ocular serotonergic intraneural fibers. We believe that it would be important for clinicians. They should keep in mind these conditions when prescribing aripiprazole and need to inform patients about the side effects related to the eye.en_US
dc.identifier.doi10.14744/nci.2019.65625
dc.identifier.endpage518en_US
dc.identifier.issn2148-4902
dc.identifier.issue5en_US
dc.identifier.pmid33163891en_US
dc.identifier.startpage516en_US
dc.identifier.trdizinid412410en_US
dc.identifier.urihttps://doi.org/10.14744/nci.2019.65625
dc.identifier.urihttps://search.trdizin.gov.tr/yayin/detay/412410
dc.identifier.urihttps://hdl.handle.net/11616/92843
dc.identifier.volume7en_US
dc.identifier.wosWOS:000579382100017en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakTR-Dizinen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherKare Publen_US
dc.relation.ispartofNorthern Clinics of Istanbulen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAripiprazolen_US
dc.subjectmyopiaen_US
dc.subjectotorefractometeren_US
dc.subjectpentacamen_US
dc.titleAripiprazole-induced transient myopiaen_US
dc.typeArticleen_US

Dosyalar